Objective: To assess the therapeutic effect of T lymphocyte subtype and liver fibrosis in chronic hepatitis B with liver fibrosis using Ganxian prescription combined with lamivudine. 目的:评价联合应用肝纤方和拉米夫定治疗慢性乙型肝炎肝纤维化患者T细胞亚群及肝纤维化指标的影响。
Analysis of anti-fibrosis effect of combining lamivudine with captopril in 166 cases with chronic hepatitis B 拉米夫定联合卡托普利治疗166例慢性乙型肝炎患者的抗肝纤维化疗效分析
Effect of Lamivudine Combined with Silybin Meglumine in the Treatment of Chronic Hepatitis B Liver Cirrhosis 拉米夫定并水飞蓟宾葡甲胺治疗乙肝活动性肝硬化
Clinical observation on lamivudine for treatment of hepatitis B virus-related hepatocellular carcinoma 拉米夫定联合肝动脉化疗对乙肝后肝癌病人的临床治疗观察
Combination of lamivudine and interferon deserves further assessment. 拉米夫啶和干扰素联合治疗值得进一步研究。
A meta-analysis of adefovir dipivoxil alone or in combination with lamivudine in patients with Lamivudine-refractory chronic hepatitis B 阿德福韦酯单用或联合拉米夫定治疗拉米夫定耐药慢性乙型肝炎的Meta分析
Combination lamivudine and matrine, a Chinese herbal medicine, in the treatment of chronic hepatitis B patients with hyperbilirubinemia 拉米夫定和苦参碱治疗伴高胆红素血症的慢性乙型肝炎临床观察
Objective To test the therapy and prevention effect of lamivudine on HBV reactivation in HBV carrier with immuno default. 目的观察拉米夫定对免疫受损宿主HBV再激活的预防和治疗作用。
Objective To observe the effects of solanum nigrum clearing liver decoction combined with interferon and lamivudine on chronic hepatitis b. 目的探讨龙葵清肝汤配合干扰素、拉米夫定治疗慢性乙型病毒性肝炎的疗效。
It is effective and safe that preventing HBV reactivation by lamivudine in a short term. 预防性短期使用拉米夫定预防HBV再激活是有效及安全的。
Cost-effectiveness analysis of two methods in the treatment of chronic hepatitis B resistant to lamivudine 两组治疗拉米夫定耐药慢性乙型肝炎方法的成本-效果分析
Lamivudine therapy might not prevent perinatal transmission of HBV infection in every newborn. 说明拉米夫定治疗不能阻断所有新生儿围产期的母婴传播。
Serum HBsAg kinetics in predicting the response of chronic hepatitis B patients treated with lamivudine 血清HBsAg动力学变化对慢性乙型肝炎拉米夫定治疗应答的影响
Lamivudine and interferon combination with or without lamivudine priming showed encouraging results in clinical trial. 在临床应用中,拉米夫啶和干扰素(拉米夫啶联用或不与拉米夫啶联用)显示了令人振奋的效果。
Patients with chronic hepatitis B developing lamivudine resistance are at high risk of disease progression and death. 对拉米夫定耐药的慢性乙肝患者面临着病情恶化甚至死亡的危险。
The composition ratio of Lamivudine decreased year by year, but the DDDs was always the top1; 在药品构成比中拉米夫定逐年下降,但在用药频度排序中,始终为第一位;
Objective: To explore the possibility of a YMDD mutations in the lamivudine untreated patients with chronic hepatitis B. 结论:显示在未经抗病毒治疗的慢乙肝患者中存在YMDD变异株,其与野生株一样是自然存在。
Conclusion The adjuvant treatment of liver cirrhosis with lamivudine results are satisfactory, is worthy of clinical use. 结论拉米夫定辅助治疗乙肝肝硬化效果理想,值得临床推广使用。
ObjectiveTo investigate the pharmacokinetic interaction of lamivudine and bicyclol after multiple dosing in rats. 目的研究大鼠多次口服双环醇和拉米夫定后对两药血浆药代动力学的影响。
Objective To observe the lamivudine treatment of hepatitis B cirrhosis effects and improve the level of clinical treatment. 目的观察拉米夫定治疗乙肝肝硬化的临床效果,提高临床治疗水平。
METHODS: Australian and New Zealand patients who received low-dose HBIG plus lamivudine following liver transplantation for HBV-related end-stage liver disease were studied. 方法:对澳大利亚和新西兰与HBV有关的晚期肝病经肝移植后接受低剂量HBIG联合拉米夫定的患者进行了研究。
Examples of drugs in the class are lamivudine, entecavir and adefovir. 这类药物的例子包括拉米夫定、恩替卡韦及阿德福韦。
To study the influence of EVR on the treatment of chronic hepatitis B with Lamivudine. 研究影响拉米夫定治疗慢性乙肝疗效的因素。
Effect of combined use of stavudine, lamivudine and nevirapine on AIDS patients Lamivudine and interferon combination with or without lamivudine priming showed encouraging results in clinical trial. 司他夫定、拉米夫定、奈韦拉平联合治疗AIDS效果在临床应用中,拉米夫啶和干扰素(拉米夫啶联用或不与拉米夫啶联用)显示了令人振奋的效果。
The dependability analysis in a year of the rapid virological response in lamivudine antiviral therapy 拉米夫定抗病毒治疗快速病毒学应答与一年疗效的相关性分析
We hypothesized that alternate rounds of lamivudine and alpha interferon might circumvent previous shortcomings. 我们假设,使用交替使用拉米夫定和α干扰素可能规避不足之处。
Observations on sequential treatment with lamivudine and interferon-α in patients with chronic hepatitis B 拉米夫定与α-干扰素序贯治疗慢性乙型肝炎疗效观察
Lamivudine is a typical antivirus agent of pyrimidine nucleoside, mainly used for the treatment of hepatitis B. 拉米夫定是一种嘧啶核苷类抗病毒药物,主要用于慢性乙型肝炎的治疗。
A clinical study of adefovir dipivoxil and lamivudine in the treatment of cirrhosis resulting from active chronic hepatitis 阿德福韦酯和拉米夫定治疗活动性肝炎肝硬化的临床比较